#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
CS

29. 12. 2025 Source: Transfusion and Haematology Today | 4/2025

Generational shift of the treatment of classical Hodgkin lymphoma

29. 12. 2025 Source: Transfusion and Haematology Today | 4/2025

Treatment of patients with relapsed or refractory diffuse large B-cell lymphoma in the Czech Republic in 2025

29. 12. 2025 Source: Transfusion and Haematology Today | 4/2025

Treatment of patients with relapsed or refractory diffuse large B-cell lymphoma in the Czech Republic in 2025

29. 12. 2025 Source: Transfusion and Haematology Today | 4/2025

Modern therapeutic approaches in the treatment of relapsed and refractory marginal zone lymphoma

29. 12. 2025 Source: Transfusion and Haematology Today | 4/2025

Follicular lymphoma –⁠ current perspective on treatment with emphasis on chemo free strategies

29. 12. 2025 Source: Transfusion and Haematology Today | 4/2025

Treatment of relapsed/refractory diffuse large B-cell lymphoma and the real-world data perspective

29. 12. 2025 Source: Transfusion and Haematology Today | 4/2025

Early isolated central nervous system relapse of mantle cell lymphoma successfully treated with ibrutinib and CAR T-cell therapy

29. 12. 2025 Source: Transfusion and Haematology Today | 4/2025

Guidelines for the management of adverse events following CD19 CAR-T cell therapy in adult patients with lymphomas and acute lymphoblastic leukaemia –⁠ consensus of expert panel from certifie…

29. 12. 2025 Source: Transfusion and Haematology Today | 4/2025

29. 12. 2025 Source: Transfusion and Haematology Today | 4/2025

29. 12. 2025 Source: Transfusion and Haematology Today | 4/2025

29. 12. 2025 Source: Transfusion and Haematology Today | 4/2025

29. 12. 2025 Source: Transfusion and Haematology Today | 4/2025
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#